Versant Side Fund III, L.P. 3
3 · Skye Bioscience, Inc. · Filed Aug 28, 2023
Insider Transaction Report
Form 3
Versant Ventures III, LLC
10% Owner
Holdings
- 2,946,924(indirect: By Versant Side Fund III, L.P.)
Common Stock
- (indirect: By Versant Venture Capital III, L.P.)
Warrant (Right to Buy)
Exercise: $0.02From: 2023-08-18Exp: 2033-08-18→ Common Stock (130,043,230 underlying) - (indirect: By Versant Side Fund III, L.P.)
Warrant (Right to Buy)
Exercise: $0.02From: 2023-08-18Exp: 2033-08-18→ Common Stock (768,124 underlying) - 498,978,878(indirect: By Versant Venture Capital III, L.P.)
Common Stock
Footnotes (2)
- [F1]Securities are directly held by Versant Venture Capital III, L.P. ("Versant III"). Versant Ventures III, LLC ("Versant Ventures III") is the sole general partner of Versant III and may be deemed to share voting and dispositive power over the securities held by Versant III. Versant Ventures III disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein.
- [F2]Securities are directly held by Versant Side Fund III, L.P. ("Side Fund III"). Versant Ventures III is the sole general partner of Side Fund III and may be deemed to share voting and dispositive power over the securities held by Side Fund III. Versant Ventures III disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein.